not logged in
Acknowledgements
MPE would like to thank the following organisations and stakeholders for their support, contributions and advice provided to creating the Myeloma Access Atlas (in alphabetical order).
- Amgen
- AstraZeneca
- AR Difusion
- Avedis Donabedian Research Institute
- Bristol Myers Squibb
- Eric Low Consulting
- GSK
- Janssen
- Karyopharm
- Mundipharma
- Novartis
- Oncopeptides
- Patvocates
- Pfizer
- Roche
- Sanofi
- Takeda
MPE would like to extend a special thank you to the pharmaceutical companies that routinely provide us with the data used to populate the Atlas. We’d like to specifically highlight and acknowledge the vital in-kind support Pfizer has provided us via strategic partnership with IQVIA.
MPE would also like to extend a huge thank-you to our members and myeloma doctors who continue to review and provide data to the Atlas.
